1. Clinical Benefits of Telotristat Ethyl in Patients With Neuroendocrine Tumors and Low Bowel Movement Frequency: An Observational Patient-Reported Outcomes Study. Issue 3 (March 2020) Authors: Benson, Al B.; Strosberg, Jonathan; Joish, Vijay N.; Dharba, Samyukta; Sapre, Dipa; Lapuerta, Pablo Journal: Pancreas Issue: Volume 49:Issue 3(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Development of sotagliflozin, a dual sodium-dependent glucose transporter 1/2 inhibitor. (March 2015) Authors: Lapuerta, Pablo; Zambrowicz, Brian; Strumph, Paul; Sands, Arthur Journal: Diabetes & vascular disease research Issue: Volume 12:Number 2(2015:Mar.) Page Start: 101 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Economic analysis of inadequate symptom control in carcinoid syndrome in the United States. (10th August 2018) Authors: Burton, Tanya; Lapuerta, Pablo Journal: Future oncology Issue: Volume 14:Number 23(2018) Page Start: 2361 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. Efficacy and safety of sotagliflozin in patients with type 2 diabetes and severe renal impairment. Issue 12 (20th August 2021) Authors: Cherney, David Z. I.; Ferrannini, Ele; Umpierrez, Guillermo E.; Peters, Anne L.; Rosenstock, Julio; Carroll, Amy K.; Lapuerta, Pablo; Banks, Phillip; Agarwal, Rajiv Journal: Diabetes, obesity & metabolism Issue: Volume 23:Issue 12(2021) Page Start: 2632 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. In Reply: Telotristat Ethyl for Patients With Carcinoid Syndrome Associated With Chest Pain and Hypertension. Issue 9 (October 2018) Authors: Jiang, Wenjun; Perez-Olle, Raul; Lapuerta, Pablo Journal: Pancreas Issue: Volume 47:Issue 9(2018) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. Long‐Term Safety Experience with Telotristat Ethyl Across Five Clinical Studies in Patients with Carcinoid Syndrome. (16th January 2019) Authors: Anthony, Lowell B.; Kulke, Matthew H.; Caplin, Martyn E.; Bergsland, Emily; Öberg, Kjell; Pavel, Marianne; Hörsch, Dieter; Warner, Richard R.P.; O'Dorisio, Thomas M.; Dillon, Joseph S.; Lapuerta, Pablo; Kassler‐Taub, Kenneth; Jiang, Wenjun Journal: Oncologist Issue: Volume 24:Number 8(2019) Page Start: e662 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. Serotonin levels and 1-year mortality in patients with neuroendocrine tumors: a systematic review and meta-analysis. (8th February 2019) Authors: Joish, Vijay N; Shah, Sandip; Tierce, Jonothan C; Patel, Deep; McKee, Chad; Lapuerta, Pablo; Zacks, Jerome Journal: Future oncology Issue: Volume 15:Number 12(2019) Page Start: 1397 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Sotagliflozin added to optimized insulin therapy leads to HbA1c reduction without weight gain in adults with type 1 diabetes: A pooled analysis of inTandem1 and inTandem2. Issue 11 (28th July 2020) Authors: Rodbard, Helena W.; Giaccari, Andrea; Lajara, Rosemarie; Stewart, John; Strumph, Paul S.; Oliveira, Juliana; Lapuerta, Pablo; Castro, Rita Journal: Diabetes, obesity & metabolism Issue: Volume 22:Issue 11(2020) Page Start: 2089 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. Study Design and Rationale of a Dose‐Ranging Trial of LX4211, a Dual Inhibitor of SGLT1 and SGLT2, in Type 2 Diabetes Inadequately Controlled on Metformin Monotherapy. Issue 7 (29th April 2013) Authors: Lapuerta, Pablo; Rosenstock, Julio; Zambrowicz, Brian; Powell, David R.; Ogbaa, Ike; Freiman, Joel; Cefalu, William T.; Banks, Phillip; Frazier, Kenny; Kelly, Mike; Sands, Arthur Journal: Clinical cardiology Issue: Volume 36:Issue 7(2013:Jul.) Page Start: 367 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. TELEPRO: Patient‐Reported Carcinoid Syndrome Symptom Improvement Following Initiation of Telotristat Ethyl in the Real World. (12th June 2019) Authors: Strosberg, Jonathan; Joish, Vijay N.; Giacalone, Susan; Perez‐Olle, Raul; Fish‐Steagall, Ann; Kapoor, Kanika; Dharba, Sam; Lapuerta, Pablo; Benson, Al B. Journal: Oncologist Issue: Volume 24:Number 11(2019) Page Start: 1446 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗